Volume 8, Issue 5, Pages (November 2008)

Slides:



Advertisements
Similar presentations
Volume 10, Issue 4, Pages (October 2009)
Advertisements

Volume 9, Issue 3, Pages (March 2009)
Beatrice M. Filippi, Clair S. Yang, Christine Tang, Tony K.T. Lam 
Volume 1, Issue 2, Pages (February 2005)
Volume 144, Issue 4, Pages (April 2013)
Volume 11, Issue 1, Pages (January 2010)
Volume 15, Issue 4, Pages (April 2012)
Volume 16, Issue 10, Pages (September 2016)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Volume 12, Issue 6, Pages (December 2010)
Volume 11, Issue 5, Pages (May 2010)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 17, Issue 5, Pages (May 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 22, Issue 3, Pages (March 2015)
Volume 19, Issue 4, Pages (April 2014)
Volume 21, Issue 11, Pages (December 2017)
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 17, Issue 5, Pages (May 2013)
Volume 22, Issue 1, Pages (July 2015)
Volume 15, Issue 5, Pages (May 2012)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 12, Issue 5, Pages (November 2010)
Volume 18, Issue 5, Pages (November 2013)
Volume 12, Issue 5, Pages (November 2010)
Volume 10, Issue 1, Pages (July 2009)
Volume 20, Issue 1, Pages (July 2014)
Volume 9, Issue 3, Pages (March 2009)
Volume 15, Issue 3, Pages (March 2008)
Volume 16, Issue 7, Pages (August 2016)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 17, Issue 5, Pages (May 2013)
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Volume 13, Issue 3, Pages (March 2011)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 1, Issue 1, Pages (January 2005)
Volume 12, Issue 5, Pages (November 2010)
Volume 6, Issue 4, Pages (October 2007)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 5, Issue 5, Pages (May 2007)
Volume 22, Issue 2, Pages (August 2015)
Volume 6, Issue 1, Pages (July 2007)
Volume 9, Issue 5, Pages (May 2009)
Volume 8, Issue 1, Pages (July 2008)
Volume 8, Issue 5, Pages (November 2008)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Volume 12, Issue 6, Pages (December 2010)
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 14, Issue 2, Pages (August 2011)
Volume 5, Issue 6, Pages (June 2007)
Volume 22, Issue 2, Pages (August 2015)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
Volume 6, Issue 4, Pages (October 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Volume 2, Issue 2, Pages (August 2005)
Volume 18, Issue 1, Pages (July 2013)
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Volume 132, Issue 3, Pages (February 2008)
Of Mice and Men: Not ExAKTly the Same?
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Regulation of Gluconeogenesis by Krüppel-like Factor 15
Presentation transcript:

Volume 8, Issue 5, Pages 437-445 (November 2008) Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice  Cédric Dray, Claude Knauf, Danièle Daviaud, Aurélie Waget, Jérémie Boucher, Marie Buléon, Patrice D. Cani, Camille Attané, Charlotte Guigné, Christian Carpéné, Rémy Burcelin, Isabelle Castan-Laurell, Philippe Valet  Cell Metabolism  Volume 8, Issue 5, Pages 437-445 (November 2008) DOI: 10.1016/j.cmet.2008.10.003 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Apelin Decreases Glycemia and Stimulates Glucose Turnover and Utilization in WT Mice (A) Effect of various apelin doses (A, 40 pmol/kg; B, 100 pmol/kg; C, 200 pmol/kg; D, 1000 pmol/kg; E, 2000 pmol/kg) i.v. injected every 45 min on blood glucose (black circles) compared to PBS-injected mice (white circles). Results are the mean ± SEM of five mice per group. ∗p < 0.05, ∗∗p < 0.01. (B) OGTT in 6-hr-fasted mice i.v. injected with either PBS (white circles) or 200 pmol/kg apelin (black circles). Results are the mean ± SEM of six mice per group. ∗p < 0.05, ∗∗∗p < 0.005 versus control. (C) Glucose turnover (TO) and associated glycolysis and glycogen synthesis (Gln Synt) rates in basal conditions and during an euglycemic-hyperinsulinemic clamp in control (white bars) and apelin-infused (75 pmol/kg/min) mice (black bars). The results are the mean ± SEM of five mice per group. ∗p < 0.05, ∗∗∗p < 0.005. (D) Tissue glucose utilization during an euglycemic-hyperinsulinemic clamp in PBS- (white bars) and apelin-infused (75 pmol/kg/min) mice (black bars). The results are the mean ± SEM of five mice per group. ∗p < 0.05 versus saline. (E) Quantification of APJ mRNA by real-time PCR in different tissues. Results are the mean ± SEM; n = 5. (F) Glucose uptake measured in isolated soleus muscles incubated with apelin and/or insulin at the indicated concentrations. Values are the mean ± SEM; n = 5–9. ∗p < 0.05, ∗∗ p < 0.01 versus basal, °p < 0.05 versus 100 nM insulin. Cell Metabolism 2008 8, 437-445DOI: (10.1016/j.cmet.2008.10.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 Apelin Effect on Glucose Utilization Is eNOS Dependent (A) Representative blot of in vitro time-course study of eNOS phosphorylation in soleus muscles by apelin (1 μM) and dose response at the indicated apelin concentrations (incubation time with apelin: 20 min). The graph shows the quantified data; n = 3. ∗p < 0.05, ∗∗p < 0.01. (B) In vivo eNOS phosphorylation in soleus muscle 20 min after an iv injection of 200 pmol/kg apelin or PBS (control) in 6-hr-fasted mice. (C and D) Measure of GIR (C) and tissue glucose utilization (D) during an euglycemic-hyperinsulinemic clamp in apelin- (gray bars) and saline-infused (hatched bars) control mice and in apelin- (black bars) and saline-infused (white bars) eNOS−/− mice. The results are the mean ± SEM of four mice per group and per tissue. ∗p < 0.05, ∗∗p < 0.01. (E) Effect of apelin and insulin on glucose uptake in soleus muscle isolated from eNOS−/− mice. The results are the mean ± SEM; n = 4. ∗p < 0.05 versus basal. Cell Metabolism 2008 8, 437-445DOI: (10.1016/j.cmet.2008.10.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 Involvement of AMPK and Akt in Apelin-Induced Glucose Transport in Soleus Muscle (A) Representative blot of in vitro time-course study of AMPK and ACC phosphorylation in soleus muscles by apelin (1 μM) and dose response (incubation time with apelin: 20 min). Two millimolar 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside (AICAR) for 1 hr was used as a positive control. The graph shows the quantified data; n = 3–4; ∗p < 0.05, ∗∗p < 0.01. (B) In vivo AMPK and ACC phosphorylation in soleus muscle 20 min after an i.v. injection of 200 pmol/kg apelin or PBS (control) in 6-hr-fasted mice. (C) Effect of 20 μM C compound on AMPK phosphorylation (top) and glucose transport (bottom) stimulated by apelin in isolated soleus muscle. Values are the mean ± SEM, n = 5. ∗p < 0.05 versus basal and °p < 0.05 versus apelin. (D) Measure of tissue glucose utilization during an euglycemic-hyperinsulinemic clamp in apelin- (black bars) and saline-infused (white bars) DN-AMPK mice and in apelin- (gray bars) and saline-infused (hatched bars) WT mice. The results are the mean ± SEM of 3–6 mice per group and per tissue. ∗p < 0.05, ∗∗p < 0.01. (E) Representative blot of in vitro time-course study of Akt phosphorylation in soleus muscles by apelin (1 μM) and dose response (incubation time with apelin: 30 min). Insulin (100 nM) for 1 hr in time-course study or 30 min in the dose response was used as a positive control. The graphs show the quantified data, n = 3–4. ∗p < 0.05. (F) Effect of 25 μM LY294002 on Akt phosphorylation (top) and glucose transport (bottom) stimulated by apelin or insulin in isolated soleus muscle. Values are the mean ± SEM, n = 3–4. ∗p < 0.05 versus basal and °p < 0.05 versus apelin or insulin. (G) Left: Akt and eNOS phosphorylation in isolated soleus muscle of WT and DN-AMPK mice incubated without (C) or with 10 nM apelin (A). The graph shows the quantified data n = 3 of Akt (black bars) and eNOS (gray bars). Middle: effect of 25 μM LY294002 on AMPK and Akt phosphorylation in soleus muscle of WT mice in the presence or not of 10 nM apelin or 100 nM insulin (incubation time: 30 min). The graph shows the quantified data, n = 3. ∗p < 0.05 versus control. Right: In vivo AMPK and Akt phosphorylation in soleus muscle, 20 min after an i.v. injection of 200 pmol/kg apelin or PBS (control), in 6-hr-fasted eNOS−/− mice. Cell Metabolism 2008 8, 437-445DOI: (10.1016/j.cmet.2008.10.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Apelin Improves Glucose Tolerance and Glucose Utilization in HF-Fed Insulin-Resistant Mice (A) OGTT performed in 6-hr fasted insulin-resistant mice i.v. injected with PBS (white square) or 200 pmol/kg apelin (black squares). The results are the mean ± SEM of six mice per group. ∗p < 0.05. (B) Basal glucose TO in control (white bars) and apelin-infused (75 pmol/kg/min) mice (black bars). The results are the mean ± SEM of six mice per group. ∗p < 0.05. (C) GIR during an euglycemic-hyperinsulinemic clamp in chow-fed and HF-fed mice infused with saline (white bars) or apelin (75 pmol/kg/min) (black bars). The results are the mean ± SEM of six mice per group. ∗p < 0.05 versus saline °p < 0.05 versus chow-fed mice. (D) Tissue glucose utilization during an euglycemic-hyperinsulinemic clamp in saline- (white bars) and apelin-infused (75 pmol/kg/min) (black bars) mice. The results are the mean ± SEM of five mice per group and per tissue. ∗p < 0.05 versus saline. Cell Metabolism 2008 8, 437-445DOI: (10.1016/j.cmet.2008.10.003) Copyright © 2008 Elsevier Inc. Terms and Conditions